Federica Cavallo

24PUBLICATIONS
138CO-AUTHORS
Predictive and prognostic markersRadiation therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jun 25, 2026
RENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma.

|May 04, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.

|Mar 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Mar 08, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.

Alessandra Tucci, Alessandro Re, Chiara Pagani

|Jan 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.

Simone Ragaini, Anna Galli, Elisa Genuardi

Pageof 4

Frequent Collaborators

9 joint publications

Simone Ferrero

6 joint publications

Vittorio Ruggero Zilioli

6 joint publications

Simone Ragaini

5 joint publications

Luca Arcaini